Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational STudy to Evaluate the EFfectiveness of OnLife® in Improving Chemotherapy-induced peripherAl NeurOpathy in Patients With Colon or Breast Cancer After End of Adjuvant Therapy

NCT03065478 is registered in ClinicalTrials.gov with Swiss Medical Food AG as lead sponsor.

NCT NCT03065478
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03065478 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational STudy to Evaluate the EFfectiveness of OnLife® in Improving Chemotherapy-induced peripherAl NeurOpathy in Patients With Colon or Breast Cancer After End of Adjuvant Therapy
Lead sponsor
Swiss Medical Food AG
Phase
Observational
Overall status
Completed
Start date
November 22, 2016
Completion date
July 31, 2018
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cipn in adjuvant breast cancer patients, cipn in adjuvant colon cancer patients